Martin Ingelsson

Project leader
Alzheimers Disease / Biobanking

I earned my MD at Karolinska Institutet in 1995 and my PhD also at Karolinska in 2001. After post-doc at Harvard Medical School I continued my career at Uppsala University where I have my own research group studying alfa-synuclein pathology in different neurodegenerative disorders. I have also initiated a local brain tissue bank and have been one of the organizers behind the biobank at the Memory Disorder Unit.

My field of expertise is molecular mechanisms behind ALzheimer's disease and other neurodegenerative disorders. I am especially focused on translating this knowledge into ideas for novel diagnostics and therapeutics.

By combining the skills and technology between different research groups we can increase the chances to develop new diagnostic markers.

From my standpoint I would like to achieve new diagnostic markers for Alzheimer's disease and related disorders. By combining different powerful methods with our vast biobank and clinical knowledge, I think we have a fair chance to achieve this goal. Ultimately, I also hope to contribute to better therapies for these disorders.


Uppsala Berzelii Technology Centre for Neurodiagnostics | Email